Spectral Medical Inc. (EDTXF)
USD 0.57
(-3.03%)
USD 0.57
(-3.03%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -15.3 Million CAD | -20.99% |
| 2022 | -9.44 Million CAD | -9.75% |
| 2021 | -8.6 Million CAD | 5.37% |
| 2020 | -9.08 Million CAD | -92.97% |
| 2019 | -4.71 Million CAD | -195.11% |
| 2018 | -1.59 Million CAD | 59.48% |
| 2017 | -3.93 Million CAD | 61.45% |
| 2016 | -10.21 Million CAD | -6.35% |
| 2015 | -9.6 Million CAD | 5.45% |
| 2014 | -10.16 Million CAD | 10.6% |
| 2013 | -11.36 Million CAD | -31.95% |
| 2012 | -8.61 Million CAD | -27.09% |
| 2011 | -6.77 Million CAD | -4.44% |
| 2010 | -6.49 Million CAD | -152.33% |
| 2009 | -2.57 Million CAD | -54.38% |
| 2008 | -1.66 Million CAD | 3.42% |
| 2007 | -1.72 Million CAD | -11.87% |
| 2006 | -1.54 Million CAD | 72.92% |
| 2005 | -5.69 Million CAD | -3.77% |
| 2004 | -5.48 Million CAD | -19.46% |
| 2003 | -4.59 Million CAD | -38.14% |
| 2002 | -3.32 Million CAD | 39.6% |
| 2001 | -5.5 Million CAD | 26.6% |
| 2000 | -7.5 Million CAD | 39.02% |
| 1999 | -12.3 Million CAD | 12.77% |
| 1998 | -14.1 Million CAD | -2.17% |
| 1997 | -13.8 Million CAD | 9.21% |
| 1996 | -15.2 Million CAD | -32.17% |
| 1995 | -11.5 Million CAD | -125.49% |
| 1994 | -5.1 Million CAD | -70.0% |
| 1993 | -3 Million CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -2.32 Million CAD | 24.08% |
| 2024 Q2 | -4.09 Million CAD | -129.31% |
| 2023 Q3 | -2.94 Million CAD | 27.04% |
| 2023 FY | -11.42 Million CAD | -20.99% |
| 2023 Q4 | -3.05 Million CAD | -3.91% |
| 2023 Q1 | -1.66 Million CAD | -104.29% |
| 2023 Q2 | -4.03 Million CAD | -142.1% |
| 2022 Q1 | -2.67 Million CAD | -4.65% |
| 2022 Q2 | -2.85 Million CAD | -6.61% |
| 2022 Q3 | -3.09 Million CAD | -8.19% |
| 2022 FY | -9.44 Million CAD | -9.75% |
| 2022 Q4 | -815 Thousand CAD | 73.62% |
| 2021 Q2 | -2.29 Million CAD | -40.44% |
| 2021 FY | -8.6 Million CAD | 5.37% |
| 2021 Q4 | -2.56 Million CAD | -20.93% |
| 2021 Q3 | -2.11 Million CAD | 7.64% |
| 2021 Q1 | -1.63 Million CAD | 18.85% |
| 2020 Q2 | -1.72 Million CAD | 55.81% |
| 2020 FY | -9.08 Million CAD | -92.97% |
| 2020 Q4 | -2.01 Million CAD | -37.83% |
| 2020 Q1 | -3.89 Million CAD | -186.33% |
| 2020 Q3 | -1.45 Million CAD | 15.27% |
| 2019 Q2 | -979 Thousand CAD | -3.93% |
| 2019 Q1 | -942 Thousand CAD | -212.01% |
| 2019 Q4 | -1.36 Million CAD | 4.69% |
| 2019 FY | -4.71 Million CAD | -195.11% |
| 2019 Q3 | -1.42 Million CAD | -45.86% |
| 2018 Q1 | -622 Thousand CAD | 40.31% |
| 2018 FY | -1.59 Million CAD | 59.48% |
| 2018 Q4 | 841 Thousand CAD | 255.17% |
| 2018 Q3 | -542 Thousand CAD | 57.39% |
| 2018 Q2 | -1.27 Million CAD | -104.5% |
| 2017 Q4 | -1.04 Million CAD | -27.07% |
| 2017 Q1 | -962 Thousand CAD | 7.14% |
| 2017 Q2 | -1.11 Million CAD | -15.9% |
| 2017 Q3 | -820 Thousand CAD | 26.46% |
| 2017 FY | -3.93 Million CAD | 61.45% |
| 2016 Q1 | -3 Million CAD | -24.51% |
| 2016 Q2 | -3.52 Million CAD | -17.16% |
| 2016 Q4 | -1.03 Million CAD | 60.92% |
| 2016 Q3 | -2.65 Million CAD | 24.75% |
| 2016 FY | -10.21 Million CAD | -6.35% |
| 2015 Q2 | -2.39 Million CAD | -4.41% |
| 2015 Q1 | -2.28 Million CAD | 9.27% |
| 2015 FY | -9.6 Million CAD | 5.45% |
| 2015 Q4 | -2.41 Million CAD | 3.9% |
| 2015 Q3 | -2.51 Million CAD | -5.15% |
| 2014 Q4 | -2.52 Million CAD | -25.4% |
| 2014 Q1 | -3.17 Million CAD | 13.79% |
| 2014 Q2 | -2.45 Million CAD | 22.8% |
| 2014 Q3 | -2.01 Million CAD | 17.91% |
| 2014 FY | -10.16 Million CAD | 10.6% |
| 2013 Q1 | -2.09 Million CAD | -0.38% |
| 2013 Q4 | -3.68 Million CAD | -45.4% |
| 2013 Q3 | -2.53 Million CAD | 17.11% |
| 2013 Q2 | -3.05 Million CAD | -45.94% |
| 2013 FY | -11.36 Million CAD | -31.95% |
| 2012 Q4 | -2.08 Million CAD | 0.43% |
| 2012 FY | -8.61 Million CAD | -27.09% |
| 2012 Q3 | -2.09 Million CAD | 3.41% |
| 2012 Q2 | -2.16 Million CAD | 4.2% |
| 2012 Q1 | -2.26 Million CAD | -15.75% |
| 2011 Q4 | -1.95 Million CAD | -19.85% |
| 2011 Q2 | -1.71 Million CAD | -16.42% |
| 2011 FY | -6.77 Million CAD | -4.44% |
| 2011 Q1 | -1.47 Million CAD | 27.28% |
| 2011 Q3 | -1.63 Million CAD | 4.9% |
| 2010 Q4 | -2.02 Million CAD | -55.8% |
| 2010 Q2 | -1.25 Million CAD | 34.45% |
| 2010 FY | -6.49 Million CAD | -152.33% |
| 2010 Q1 | -1.91 Million CAD | -59.83% |
| 2010 Q3 | -1.3 Million CAD | -3.91% |
| 2009 Q3 | -416 Thousand CAD | 27.78% |
| 2009 Q1 | -385 Thousand CAD | 1.03% |
| 2009 Q2 | -576 Thousand CAD | -49.61% |
| 2009 FY | -2.57 Million CAD | -54.38% |
| 2009 Q4 | -1.19 Million CAD | -187.26% |
| 2008 Q1 | -512 Thousand CAD | 34.44% |
| 2008 Q4 | -389 Thousand CAD | -1.04% |
| 2008 Q3 | -385 Thousand CAD | -0.79% |
| 2008 Q2 | -382 Thousand CAD | 25.39% |
| 2008 FY | -1.66 Million CAD | 3.42% |
| 2007 FY | -1.72 Million CAD | -11.87% |
| 2007 Q2 | -394 Thousand CAD | -72.81% |
| 2007 Q4 | -781 Thousand CAD | -108.27% |
| 2007 Q3 | -375 Thousand CAD | 4.82% |
| 2007 Q1 | -228 Thousand CAD | 0.0% |
| 2006 FY | -1.54 Million CAD | 72.92% |
| 2006 Q2 | -536 Thousand CAD | 68.49% |
| 2006 Q1 | -1.7 Million CAD | -38.41% |
| 2006 Q3 | -462 Thousand CAD | 13.81% |
| 2005 Q3 | -955 Thousand CAD | 17.39% |
| 2005 Q4 | -1.22 Million CAD | -28.69% |
| 2005 FY | -5.69 Million CAD | -3.77% |
| 2005 Q1 | -1.18 Million CAD | 34.37% |
| 2005 Q2 | -1.15 Million CAD | 2.53% |
| 2004 Q1 | -1.56 Million CAD | -26.87% |
| 2004 FY | -5.48 Million CAD | -19.46% |
| 2004 Q4 | -1.8 Million CAD | -14.22% |
| 2004 Q3 | -1.58 Million CAD | -41.12% |
| 2004 Q2 | -1.12 Million CAD | 28.28% |
| 2003 FY | -4.59 Million CAD | -38.14% |
| 2003 Q2 | -815 Thousand CAD | 61.06% |
| 2003 Q3 | -1.32 Million CAD | -62.45% |
| 2003 Q4 | -1.23 Million CAD | 6.95% |
| 2003 Q1 | -2.09 Million CAD | -442.23% |
| 2002 FY | -3.32 Million CAD | 39.6% |
| 2002 Q4 | -386 Thousand CAD | 49.08% |
| 2002 Q3 | -758 Thousand CAD | 27.39% |
| 2002 Q2 | -1.04 Million CAD | 16.41% |
| 2002 Q1 | -1.24 Million CAD | 31.34% |
| 2001 FY | -5.5 Million CAD | 26.6% |
| 2001 Q1 | -1.24 Million CAD | -87.07% |
| 2001 Q2 | 1.58 Million CAD | 227.09% |
| 2001 Q3 | -1.64 Million CAD | -204.11% |
| 2001 Q4 | -1.81 Million CAD | -10.51% |
| 2000 FY | -7.5 Million CAD | 39.02% |
| 2000 Q3 | -1.84 Million CAD | -2.44% |
| 2000 Q4 | -665 Thousand CAD | 63.94% |
| 2000 Q1 | -1.1 Million CAD | 21.43% |
| 2000 Q2 | -1.8 Million CAD | -63.64% |
| 1999 Q2 | -2.2 Million CAD | -10.0% |
| 1999 Q4 | -1.4 Million CAD | 46.15% |
| 1999 FY | -12.3 Million CAD | 12.77% |
| 1999 Q1 | -2 Million CAD | 35.48% |
| 1999 Q3 | -2.6 Million CAD | -18.18% |
| 1998 Q3 | -4.5 Million CAD | -40.63% |
| 1998 Q4 | -3.1 Million CAD | 31.11% |
| 1998 Q2 | -3.2 Million CAD | 5.88% |
| 1998 Q1 | -3.4 Million CAD | 8.11% |
| 1998 FY | -14.1 Million CAD | -2.17% |
| 1997 FY | -13.8 Million CAD | 9.21% |
| 1997 Q4 | -3.7 Million CAD | -5.71% |
| 1997 Q3 | -3.5 Million CAD | 2.78% |
| 1997 Q1 | -4.3 Million CAD | -26.47% |
| 1997 Q2 | -3.6 Million CAD | 16.28% |
| 1996 Q1 | -3.3 Million CAD | 21.43% |
| 1996 Q4 | -3.4 Million CAD | -9.68% |
| 1996 FY | -15.2 Million CAD | -32.17% |
| 1996 Q3 | -3.1 Million CAD | 0.0% |
| 1996 Q2 | -3.1 Million CAD | 6.06% |
| 1995 FY | -11.5 Million CAD | -125.49% |
| 1995 Q4 | -4.2 Million CAD | 6.67% |
| 1995 Q1 | -4 Million CAD | -66.67% |
| 1995 Q3 | -4.5 Million CAD | -18.42% |
| 1995 Q2 | -3.8 Million CAD | 5.0% |
| 1994 Q1 | -1.7 Million CAD | -21.43% |
| 1994 Q3 | -3 Million CAD | -57.89% |
| 1994 Q4 | -2.4 Million CAD | 20.0% |
| 1994 FY | -5.1 Million CAD | -70.0% |
| 1994 Q2 | -1.9 Million CAD | -11.76% |
| 1993 Q4 | -1.4 Million CAD | -16.67% |
| 1993 FY | -3 Million CAD | 0.0% |
| 1993 Q1 | -828.96 Thousand CAD | -30.42% |
| 1993 Q3 | -1.2 Million CAD | -71.43% |
| 1993 Q2 | -700 Thousand CAD | 15.56% |
| 1992 Q3 | -998.25 Thousand CAD | -178.18% |
| 1992 Q2 | -358.85 Thousand CAD | 0.0% |
| 1992 Q4 | -635.61 Thousand CAD | 36.33% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -1132.367% |
| Arrayit Corporation | -3.62 Million USD | -322.524% |
| Atlantic International Corp. | -5.73 Million USD | -167.004% |
| Biocept, Inc. | -31.98 Million USD | 52.143% |
| Bioqual, Inc. | -19.63 Thousand USD | -77840.727% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -1882.278% |
| DermTech, Inc. | -103.73 Million USD | 85.246% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.615% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 26.518% |
| iMD Companies, Inc. | -175.44 Thousand USD | -8624.052% |
| IDenta Corp. | -1499.00 USD | -1020980.72% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 645.863% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 39660.61% |
| InVitro International | -25.33 Thousand USD | -60304.909% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | -114.912% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -26238.794% |
| Medical Imaging Corp. | -819.48 Thousand USD | -1767.77% |
| NovelStem International Corp. | -3.52 Million USD | -334.114% |
| Optigenex Inc. | 1.39 Million USD | 1200.49% |
| PharmChem, Inc. | 973.14 Thousand USD | 1672.835% |
| Proteome Sciences plc | -1.62 Million USD | -844.232% |
| Response Genetics, Inc | -21.37 Million USD | 28.4% |
| Rennova Health, Inc. | -1.4 Million USD | -985.891% |
| RushNet, Inc. | -684.7 Thousand USD | -2135.415% |
| ScreenPro Security Inc. | -2.59 Million USD | -490.412% |
| Stella Diagnostics Inc. | -11.42 Million USD | -33.947% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | -97.579% |
| Todos Medical Ltd. | -9.74 Million USD | -57.017% |